GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Cerity Partners LLC

Cerity Partners LLC grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 45,929 shares of the company’s stock after acquiring an additional 9,809 shares during the period. Cerity Partners LLC’s holdings in GE HealthCare Technologies were worth $3,551,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Armstrong Henry H Associates Inc. grew its stake in shares of GE HealthCare Technologies by 3.9% in the third quarter. Armstrong Henry H Associates Inc. now owns 4,105 shares of the company’s stock valued at $279,000 after buying an additional 153 shares in the last quarter. Chicago Capital LLC grew its stake in shares of GE HealthCare Technologies by 2.8% in the third quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock valued at $414,000 after buying an additional 163 shares in the last quarter. Chilton Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 15.4% in the fourth quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after buying an additional 164 shares in the last quarter. Procyon Advisors LLC grew its stake in shares of GE HealthCare Technologies by 5.2% in the fourth quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock valued at $275,000 after buying an additional 175 shares in the last quarter. Finally, Meeder Advisory Services Inc. grew its stake in shares of GE HealthCare Technologies by 5.4% in the fourth quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock valued at $281,000 after buying an additional 185 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 0.8 %

Shares of NASDAQ GEHC opened at $85.19 on Thursday. The company has a market cap of $38.87 billion, a price-to-earnings ratio of 28.21, a price-to-earnings-growth ratio of 3.00 and a beta of 0.94. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The stock’s 50 day simple moving average is $88.61 and its 200 day simple moving average is $77.65.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.11. The business had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business’s revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business posted $1.31 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is currently 3.97%.

Analysts Set New Price Targets

GEHC has been the subject of a number of recent research reports. Mizuho increased their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. HSBC initiated coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price for the company. Argus increased their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Citigroup raised their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and raised their price objective for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $95.08.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.